Good morning,
Thank you for your feedback and we fully understand your feelings regarding the first uses of RestoreX.
The attachment of the glans to the RestoreX clamp is indeed the main constraint to effective use of the device.
This fixation must be particularly strong because the treatment relies on applying significant traction to gradually soften the fibrositis of the tunica albuginea. The clamping system has been designed to offer the best compromise between effective support and comfort, thanks to pressure distribution over a large area of the glans.
We recommend that you carefully review the instructional video regarding the application of the pad and self-adhesive bandage. If you wish, we can also arrange a phone consultation to assist you with this step.
Regarding your foreskin, it is important that it is retracted during the fitting so that the traction is exerted on the penis and not on the skin, which could explain some of the discomfort experienced.
We observed that the physiology gradually adapts to the pressure exerted by the clamp; the glans epithelium thickens and, after a few days, this mucosa becomes tougher and better able to withstand the clamping force. During the first week, we recommend using the RestoreX only with axial traction and, subsequently, applying the counter-curve to positions 1-2, then 3-4.
According to the reference clinical study (M.J. Ziegelmann & In a prospective randomized controlled trial (al.), adverse events were observed in patients using RestoreX®, but these were described as mild, transient, and without significant clinical severity. Most notably, all symptoms that occurred during treatment were mild and resolved within minutes of stopping the traction session. No adverse event led to study withdrawal or treatment discontinuation.
Finally, regarding the price of the RestoreX, we understand that the investment may seem significant.
Beyond its physical design, it is a patented medical device whose efficacy and safety have been evaluated in prospective, randomized clinical trials (control group). Research, development, clinical validation, and certification costs represent a significant portion of its value.
After only two weeks of use, it is still too early to assess the therapeutic benefits of the treatment. However, we hope that a few adjustments to the application will allow you to quickly improve your comfort during use.
We remain at your complete disposal for any further information or to answer your comments.
Best regards.